How Dr. Chi Dang uses visual thinking in cancer research

"We are understanding now that this code is there, amazing, but now how can I make this code behave in different ways?" On this episode of HYPERSCALE, I am joined by Dr. Federico, a physician specializing in genomics and regenerative medicine who founded one of Latin America's first direct-to-consumer genomics companies while still in medical school. Dr. Federico brings a unique perspective to longevity medicine, having worked with everyone from professional athletes to indigenous communities, gathering crucial health data from underrepresented populations. His approach combines cutting-edge science with a deep commitment to making precision health accessible to all. Join us as we explore how your genetic code interacts with your environment, why recovery matters more than we think, the real science behind stem cells and peptides, and why the basics of health might add 25 years to your life before we even touch advanced therapies.

I am looking forward to sharing the first public disclosure of @Asymmetrex®'s newest @RABBIT Count® algorithms for rapid, accurate, differential tissue stem cell counting, which require only the mitotic index of a tissue cell sample. Hope you will join us to learn about this latest advance in stem cell biomedicine.

This week, our own Matthew Kennedy, Aileen Pangan and Jill Abell joined leaders at the #STATSummit to participate in discussions on the future of science and medicine. Our leaders shared their thoughts on drug discovery and development in neuroscience, and emphasized the importance of keeping patients and caregivers at the center of our efforts to advance our pipeline. Through a fireside chat, we also took a deep dive into how we are working to help shape the future for immune-mediated disease research. Learn more about our work to translate scientific discoveries into treatment through research: http://merck.us/42KxpoL

In a Welch Foundation supported study, Endowed Chair Devarajan Thirumalai and The University of Texas at Austin researchers developed a theory to predict chromatin dynamics by accurately determining three-dimensional structures from static Hi-C contact maps or fixed-cell imaging data. https://lnkd.in/gNdCehXC

🌍 Medicine in Light — The Future Has Already Begun What if light could see disease and heal it? The Mini Holo system turns this vision into science: a holographic diagnostic sphere capable of mapping biological tissue through light coherence and phase resonance. The image below illustrates one of the key concepts from our previous post, the HoloHarmoniq White Paper 2025, where we explore how biophotonics and quantum resonance may redefine early cancer detection and regenerative medicine. At HoloHarmoniq Ltd, we believe medicine is entering its photonic era, where biology, light, and quantum physics converge to restore harmony in living systems. “The future of medicine begins in light.” #QuantumBiology #Biophotonics #MedicalInnovation #HoloHarmoniq #DeepTech #HealthcareTechnology

The future of Alzheimer’s and related dementias research lies in the power of large-scale datasets and global collaboration. This month, we’re launching the Global Neurodegeneration Proteomics Consortium (GNPC) Data Challenge to continue moving this vision forward.  Researchers will have the opportunity to analyze nearly the world’s largest proteomics dataset for neurodegeneration – nearly 250 million protein measurements from 35,000 biosamples across 20+ international cohorts. With the analytical power of AD Workbench, researchers will demonstrate how open science and large-scale proteomics accelerate Alzheimer’s research. But don’t just take our word for it—Caitlin Finney from The Westmead Institute for Medical Research shares her perspective on the value of generating and sharing comprehensive datasets for #ADRD ⬇️

At ChemBioParis2025, we just heard an inspiring keynote address by Professor Chris Chang from Princeton University.    Prof. Chang is internationally known for developing chemical tools to study transition metals in biology. His group develops sensors and proteomics probes to uncover roles of metals in signaling and disease.    In his keynote lecture, “Transition Metal Signaling, Metalloallostery, and Metalloplasias: Bioinorganic Chemistry Beyond Active Sites”, he shared innovative work on how metals shape processes in neuroscience, cancer, and metabolic diseases.    #ChemBioParis2025 #EUOPENSCREEN #ECBS #ICBS #EUOSImpulse INTERNATIONAL CHEMICAL BIOLOGY SOCIETY EuChemS (European Chemical Society) EU-OPENSCREEN SCF-ChemBio 

Check out the upcoming UIDP Webinar: Inside the NEURO360 Initiative. This regional collaboration, led by Washington University in St. Louis and BioSTL, unites academia, industry, investors, entrepreneurs, and community partners to accelerate neuroscience research. The goal is to translate discoveries into products, services, and policies that enhance health and create economic opportunities. Companies in the medical device and diagnostic sectors will learn how they can engage with NEURO360 and contribute to shaping the future of brain science. For more details, visit the link: https://lnkd.in/gwczkgKv

Event recap video of Dr. Lauren Albrecht's lab tour during the Day of Hope Family Conference. Middle- and high-school-aged children living with cystinosis were given a hands-on look at the Albrecht Lab’s research by: - Looking at real-time visuals of biological processes through live cell imaging technology - Seeing cell processes in glowing colors under the lab's fluorescent microscope - Extracting DNA from strawberries. - Looking at Caenorhabditis elegans (C. elegans) worms under a microscope Cystinosis is a genetic condition characterized by a buildup of cystine (an amino acid) in the cells. This buildup of cystine, which forms crystals, damages cells, primarily affecting the kidneys and eyes.

Here is what separates successful scientists from those who lead their field. (Its not the brilliance of their ideas.) I have worked with hundreds of leaders in their field. They all have this trait. Persistence. The 2025 winners of the Nobel Prize for Medicine and Physiology announced today are no exception. They work for years and sorted through 500.000 nucleotides to convince their field that regulatory T-cells exist and they have an extremely important role. What would have happened if they were not persistent? There work was a key advancement that is likely to help treat cancer and autoimmune diseases. To be more persistent: ⤷ Become comfortable with uncertainty ⤷ Develop a careful approach to dissecting mechanisms, so that you don't have to race to be first.